We catch up with Kimryn Rathmell on her first day as CEO at OSUCCC – James

Pfizer seeks to improve breast cancer outcomes in Sub-Saharan Africa
With help from Conquer Cancer’s EveryGrant and ASCO’s Sub-Saharan Africa Regional Council, Pfizer awards grants to seven countries

The other side of the patient portal: Reflections from a cancer center leader

Surviving cancer is often not a patient’s most challenging battle

ODAC marathon: Committee charges through a pileup of clinical questions in a two-day, four-application session

Cancer Policy

A farewell post by an unidentified NCI employee triggers an accusation of “undermining the Trump administration”

RFK Jr. floats the idea of barring government scientists from publishing in leading medical journals due to “corruption”

Trump releases executive order that demands “Restoring Gold Standard Science”

U.S. halts foreign student visas, Rubio vows to revoke visas of students from China

MAHA report “Making our Children Healthy Again” focuses on ultraprocessed foods and is mum on tobacco

The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo

Clinical Roundup

Most Americans unaware of cancer risks associated with drinking alcohol

Efti + radiotherapy + Keytruda regimen meets primary endpoint in phase II study in soft tissue sarcoma

Wildfire pollution may lower survival of lung cancer patients

New biomarker may guide best use of KRAS inhibitors in lung cancer

Targeted strategy prevents untreatable nerve pain caused by chemotherapy

“Fast-fail” AI blood test could steer patients with pancreatic cancer away from ineffective therapies

In The Clinic

Biden’s diagnosis is unfortunate but—statistically—not surprising
Of the 384 men serving in Congress, 48 are likely to be diagnosed with prostate cancer in their lifetime

Unlocking the future of precision medicine:
The untapped power of RNA

A new AI tool enables speedy use of ASCO guidelines, eliminating typical errors

Kennedy’s claims notwithstanding, NCI clinical trials are delayed, enrollments reduced
NCI’s Steven A. Rosenberg: “Almost all patients are getting delayed by about a month, but then again, we’re turning away more patients.”

Working with cancer: Rethinking long-term health for working-age adult cancer survivors

Latest Issue

NEWS ALERTS

Stay up to date on the latest news in oncology by joining our mailing list.

UPCOMING EVENTS

Jul 2025

Sep 2025

Oct 2025

Conversations with The Cancer Letter

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy

Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed

Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State

Contributors

Enrique Velazquez Villarreal, MD, PhD, MPH, MS

Wafik S. El-Deiry, MD, PhD

Mace L. Rothenberg, MD

City of Hope

We catch up with Kimryn Rathmell on her first day as CEO at OSUCCC – James

Pfizer seeks to improve breast cancer outcomes in Sub-Saharan Africa
With help from Conquer Cancer’s EveryGrant and ASCO’s Sub-Saharan Africa Regional Council, Pfizer awards grants to seven countries

The other side of the patient portal: Reflections from a cancer center leader

Surviving cancer is often not a patient’s most challenging battle

ODAC marathon: Committee charges through a pileup of clinical questions in a two-day, four-application session

A farewell post by an unidentified NCI employee triggers an accusation of “undermining the Trump administration”

RFK Jr. floats the idea of barring government scientists from publishing in leading medical journals due to “corruption”

Trump releases executive order that demands “Restoring Gold Standard Science”

U.S. halts foreign student visas, Rubio vows to revoke visas of students from China

MAHA report “Making our Children Healthy Again” focuses on ultraprocessed foods and is mum on tobacco

The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo

Most Americans unaware of cancer risks associated with drinking alcohol

Efti + radiotherapy + Keytruda regimen meets primary endpoint in phase II study in soft tissue sarcoma

Wildfire pollution may lower survival of lung cancer patients

New biomarker may guide best use of KRAS inhibitors in lung cancer

Targeted strategy prevents untreatable nerve pain caused by chemotherapy

“Fast-fail” AI blood test could steer patients with pancreatic cancer away from ineffective therapies

Biden’s diagnosis is unfortunate but—statistically—not surprising
Of the 384 men serving in Congress, 48 are likely to be diagnosed with prostate cancer in their lifetime

Unlocking the future of precision medicine:
The untapped power of RNA

A new AI tool enables speedy use of ASCO guidelines, eliminating typical errors

Kennedy’s claims notwithstanding, NCI clinical trials are delayed, enrollments reduced
NCI’s Steven A. Rosenberg: “Almost all patients are getting delayed by about a month, but then again, we’re turning away more patients.”

Working with cancer: Rethinking long-term health for working-age adult cancer survivors

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy

Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed

Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State

Enrique Velazquez Villarreal, MD, PhD, MPH, MS

Wafik S. El-Deiry, MD, PhD

Mace L. Rothenberg, MD

City of Hope

Never miss an issue!

Login

We catch up with Kimryn Rathmell on her first day as CEO at OSUCCC – James

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy

Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising recordCurrent record: $507,000. Proceeds to go to LLS as NIH funding is slashed

Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State

City of Hope

Never miss an issue!

Login

Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed